Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) IFNA Antibodies:
anti-Human IFNA Antibodies:
Go to our pre-filtered search.
Chicken Monoclonal IFNA Primary Antibody for ELISA, WB - ABIN2474115
Sick, Schultz, Staeheli: A family of genes coding for two serologically distinct chicken interferons. in The Journal of biological chemistry 1996
Show all 4 Pubmed References
Chicken Polyclonal IFNA Primary Antibody for Func, IP - ABIN2474117
Schultz, Kaspers, Rinderle, Sekellick, Marcus, Staeheli: Recombinant chicken interferon: a potent antiviral agent that lacks intrinsic macrophage activating factor activity. in European journal of immunology 1995
Show all 4 Pubmed References
Mouse (Murine) Monoclonal IFNA Primary Antibody for Func, IA - ABIN2191742
Diebold, Montoya, Unger, Alexopoulou, Roy, Haswell, Al-Shamkhani, Flavell, Borrow, Reis e Sousa: Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. in Nature 2003
Show all 2 Pubmed References
Human Monoclonal IFNA Primary Antibody for ELISA, Func - ABIN250928
Shearer, Taylor-Papadimitriou, Griffin, Balkwill: Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers. in Journal of immunology (Baltimore, Md. : 1950) 1984
Human Monoclonal IFNA Primary Antibody for IHC (fro), ELISA - ABIN2474116
Reed, Vukmanovic-Stejic, Fletcher, Soares, Cook, Orteu, Jackson, Birch, Foster, Salmon, Beverley, Rustin, Akbar: Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. in The Journal of experimental medicine 2004
Mouse (Murine) Monoclonal IFNA Primary Antibody for Func, IHC (fro) - ABIN2474118
Wheat: Eimeria Macyi sp. n. (Protozoa: Eimeriidae) from the eastern pipistrelle, Pipistrellus subflavus, from Alabama. in The Journal of parasitology 1976
Show all 2 Pubmed References
Mutation of the IFNAR-1 (show IFNAR1 Antibodies) receptor binding site of human IFN-alpha2 (show IFNA2 Antibodies) generates type I IFN competitive antagonists.
produced in vitro and in vivo in response to noncytopathic bovine viral diarrhea virus in lymph nodes cells expressing the myeloid markers CD14 (show CD14 Antibodies), CD11b (show ITGAM Antibodies), and CD172a (show SIRPA Antibodies)
Prolonged treatment with IFN-alpha (12-48 h) resulted in increased expression of STAT1 (show STAT1 Antibodies) and, to a lesser extent, STAT2 (show STAT2 Antibodies).
results suggest that IL-28B (show IL28B Antibodies) induces more mature NK cells to defend against viruses, in addition to its direct antiviral activity
this study introduces a novel pathway by which IFN-alpha serves as a proatherogenic mediator through repression of eNOS (show NOS3 Antibodies)-dependent pathways
study reports that mitochondrial antiviral signaling protein (MAVS (show MAVS Antibodies)), -mediated IFN-alpha/beta production and IFNAR (show IFNAR1 Antibodies) signaling are required for alloimmune responses to the human K1 Ag in a murine model of inflammation-induced alloimmunization
These findings also identify STAT3 (show STAT3 Antibodies) as a therapeutic target against viral infection and highlight it as an essential pathway component for endogenous and therapeutic IFN-alpha responsiveness.
CD169 (show SIGLEC1 Antibodies)(+) macrophages are important contributors to the IFN-I response and thereby influence antiviral activity, CD8 (show CD8A Antibodies)(+) T-cell exhaustion and immunopathology.
These results suggest that pulmonary C-fibers affect IFNGR1 (show IFNGR1 Antibodies) expression by inducing IFN-alpha to regulate IFN-gamma (show IFNG Antibodies)-mediated airway inflammation and airway hyperresponsiveness.
results show that resistance to HSV-1 in the trigeminal ganglia during acute infection is conferred in part by STING and IFN-alpha/beta signaling in both bone marrow-derived and -resident cells, which coalesce to support a robust HSV-1-specific CD8 (show CD8A Antibodies)(+) T cell response
the close association between the increased proportion of CD180 (show CD180 Antibodies)-negative B cells and the activation of IFN-alpha signaling in Systemic lupus erythematosus, is reported.
STAT2 (show STAT2 Antibodies) recruits USP18 (show USP18 Antibodies) to the type I IFN receptor subunit IFNAR2 (show IFNAR2 Antibodies) via its constitutive membrane-distal STAT2 (show STAT2 Antibodies)-binding site.
In the exorbital lachrymal gland, the mRNA expression of IFN beta (show IFNB1 Antibodies) and IFN alpha (type (show PSMA1 Antibodies) I IFNs) was weak- to strong-positive at 1 days post inoculation (DPI (show DSP Antibodies)), and became negative at 2DPI.
Collectively, these data show that porcine epidemic diarrhea virus is capable of subverting the type I interferon response by inducing STAT1 (show STAT1 Antibodies) degradation.
Amino acid residues in the N-terminal domain of Npro are involved in the stability of Npro, in interaction of Npro with IRF-3 (show IRF3 Antibodies) and subsequent degradation of IRF-3 (show IRF3 Antibodies), leading to downregulation of IFN-alpha/beta production.
Pregnane X receptor is required for interferon-alpha-mediated CYP3A29 expression, and its expression before CYP3A29.
Overall, data provide evidence for the possible role of PI3K in the activation of the transcription of IFN-alpha/beta by PRRSV; study concludes that PRRSV inhibits the induction of IFN-alpha in monocyte-derived dendritic cells by as yet undefined post-transcriptional mechanisms.
Nsp1beta inhibits interferon-activated (show MNDA Antibodies) STAT1 (show STAT1 Antibodies)/STAT2 (show STAT2 Antibodies) signal transduction by inducing karyopherin-alpha1 degradation.
Expression of Mx protein (show MX2 Antibodies) and interferon-alpha (IFN-alpha) was examined by immunohistochemistry in pigs experimentally infected with swine influenza virus.
Foot-and-Mouth Disease Virus inhibits IFN-alpha expression in infected cells by blocking cap-dependent translation.
results demonstrate that Sphingosine 1-phosphate lyase (SPL (show SGPL1 Antibodies)) is a host factor that augments type I IFN responses during influenza A virus infection; study delineates the relationship between IKKepsilon (show IKBKE Antibodies) and SPL (show SGPL1 Antibodies), which provides a mechanistic understanding of the pro-IFN activity of SPL (show SGPL1 Antibodies)
These data suggest that plasmacytoid dendritic cells producing IFN-alpha and IL-33 (show IL33 Antibodies) play a pivotal role in the chronic fibro-inflammatory responses underlying murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis.
Mothers of children affected by autoimmune congenital heart block had a significantly higher expression IFN-alpha.
Suppression of the exogenous Type I IFN-induced Jak (show JAK3 Antibodies)/STAT (show STAT1 Antibodies) signaling by NSs might be one of the mechanisms of Severe fever with thrombocytopenia syndrome (SFTS) to evade host immune surveillance.
High Type I Interferon expression due to hypomethylation is associated with Systemic Lupus Erythematosus.
these studies identify phosphorylation of S734-STAT2 (show STAT2 Antibodies) as a new regulatory mechanism that negatively controls the type I IFN-antiviral response.
The synthetic IFNP molecule exerted its antitumor activity by upregulating the downstream genes involved in the STAT1 (show STAT1 Antibodies) pathway and in apoptosis. Using a cell receptor binding assay, we showed that this Jurkat-binding peptide (show HP Antibodies) facilitated the binding affinity of IFNalpha to the cell surface type I IFN receptor
KSHV-encoded viral IRF4 (show IRF4 Antibodies) interacts with the host IRF7 (show IRF7 Antibodies) and inhibits interferon-alpha production.
Data indicate ARID3a (show ARID3A Antibodies)(+) B cells as a type of effector B cell, and link ARID3a (show ARID3A Antibodies) expression in B lymphocytes to interferon alpha (IFNa)-associated inflammatory responses in systemic lupus erythematosus (SLE).
Produced by macrophages, IFN-alpha have antiviral protein kinase and an oligoadenylate synthetase.
, interferon alpha
, interferon type A1/A2
, interferon type A3
, IFN-alpha/beta receptor 1
, interferon alpha/beta receptor 1
, interferon, alpha; receptor
, interferon-alpha/beta receptor 1
, interferon-alpha/beta receptor alpha chain
, type I interferon receptor 1
, interferon alpha family gene 1
, interferon alpha-1
, interferon alpha A
, interferon lambda-3
, interleukin 28
, interleukin 28B
, interferon alpha 1
, IFN-alpha 1b
, interferon alpha 1b
, interferon alpha-1/13
, interferon alpha-D
, leIF D
, interferon alpha-17
, interferon alpha-88
, interferon alpha-I'
, interferon alpha-T
, interferon alpha-WA
, leIF I
, interferon alpha 7